Alfred Ian Lee MD, PhD

Assistant Professor of Medicine (Hematology and FY15 Hematology); Firm Chief, Inpatient Hematology, Yale Cancer Center; Assistant Program Director, Traditional Internal Medicine Residency Program

Clinical Interests

Lymphoma; platelet disorders; thrombosis; bleeding; coagulation disorders; leukemia


Board Certifications

2013
Hematology, Internal Medicine, Board Certified
2007
Internal Medicine, Board Certified

Patient Care Locations

 
alfred_leefaculty-clinicsfalsetruetrue6truefalsefalse
 

Clinical Trials

Conditions Study Title
Hepatic Veno-Occlusive Disease, Hodgkin's Lymphoma, Leukemia, not otherwise specified, Multiple Myeloma, and Non-Hodgkin's Lymphoma Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study
Antiphospholipid Syndrome (APS) Comparison of Gut Commensal Bacteria Between Persistently anti-gamma2 Glycoprotein-I Positive Patients and Antiphospholipid Antibody Negative Patients
Ill-Defined Sites and Unknown Sites A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises
Non-Hodgkin's Lymphoma A randomized, double-blind, placebo-controlled, phase 3 study of brentuximab vedotin and CHP (A+CHP) versus CHOP in the frontline treatment of patients with CD30- positive mature T-cell lymphomas
Leukemia, not otherwise specified and Myeloid and Monocytic Leukemia An Open Label, Phase I/IIa, Dose Escalation Trial to Investigate the Maximum Tolerated Dose, Safety, Pharmacokinetics, and Efficacy of Intravenous Volasertib (BI 6727) in Combination with Decitabine in Patients with Acute Myeloid Leukemia

More Clinical Trials...

Edit Profile